Polyglutamine-containing proteins in schizophrenia

Molecular Psychiatry

Volumn 4, Issue 1, 1999, Pages 53-57

  Joober, R ^a,b   Benkelfat, C ^c   Jannatipour, M ^a   Turecki, G ^a   Lal, S ^b   Mandel, J L ^d   Bloom, D ^b   Lalonde, P ^e   Lopes Cendes, I ^a   Fortin, D ^a   Rouleau, G ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d IGBM   (France)

^e CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

Author keywords

Anticipation; CAG repeats; Neuroleptic responsiveness; Polyglutamine tracts; Schizophrenia

Indexed keywords

GLUTAMINE; MONOCLONAL ANTIBODY; POLYAMINOACID;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SCHIZOPHRENIA; TRINUCLEOTIDE REPEAT;

EID: 0032968772     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000480     Document Type: Article

References (22)

1. 1 Kendler KS, McGuire M, Gruenberg AM, O'Hare A, Spellman M, Walsh D. The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Arch Gen Psychiatry 1993; 50: 527-540.
2. 2 Cannon TD, Kaprio J, Lonnqvist J, Huttunen M, Koskenvuo M. The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch Gen Psychiatry 1998; 55: 67-74.
3. 3 Kety SS, Wender PH, Jacobsen B, Ingraham LJ, Jansson L, Faber BX et al. Mental illness in the biological and adoptive relatives of schizophrenic: adoptees. Replication of the Copenhagen Study in the rest of Denmark. Arch Gen Psychiatry 1994; 51: 442-455.
4. 4 Risch N. Genetic linkage and complex diseases, with special reference to psychiatric disorders. Genet Epidemiol 1990; 7: 3-16; discussion 17-45.
5. 5 Bassett AS, Husted J. Anticipation or ascertainment bias in schizophrenia? Penrose's familial mental illness sample. Am J Hum Genet 1997; 60: 630-637.
6. 6 Yaw J, Myles-Worsley M, Hoff M, Holik J, Freedman R, Byerley W et al. Anticipation in multiplex schizophrenia pedigrees. Psychiatric Genet 1996; 6: 7-11.
7. 7 Gorwood P, Leboyer M, Falissard B, Jay M, Rouillon F, Feingold J. Anticipation in schizophrenia: new light on a controversial problem. Am J Psychiatry 1996; 153: 1173-1177.
8. 8 Chotai J, Engstrom C, Ekholm B, son Berg ML, Adolfsson R, Nylander PO. Anticipation in Swedish families with schizophrenia. Psychiatric Genet 1995; 5: 181-186.
9. 9 Petronis A, Kennedy JL. Unstable genes - unstable mind? Am J Psychiatry 1995; 152: 164-172.
10. 10 O'Donovan MC, Owen MJ. Dynamic mutations and psychiatric genetics. Psychol Med 1996; 26: 1-6.
11. 11 O'Donovan MC, Guy C, Graddock N, Bowen T, McKoon P, Macedo A et al. Confirmation of association between expanded CAG/CTG repeats and both schizophrenia and bipolar disorder. Psychol Med 1996; 26: 1145-1153.
12. 12 Morris AG, Gaitonde E, McKenna PJ, Mollon JD, Hunt DM. CAG repeat expansions and schizophrenia: association with disease in females and with early age-at-onset. Hum Mol Genet 1995; 4: 1957-1961.
13. 13 O'Donovan MC, Guy G, Graddock N, Murphy KC, Cardno AG, Jones LAX et al. Expanded GAG repeats in schizophrenia and bipolar disorder. Nature Genet 1995; 10: 380-381.
14. 14 Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, Das SS et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 1997; 19: 333-344.
15. 15 Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, Cancel G et al. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 1995; 378: 403-406.
16. 16 Stevanin G, Trottier Y, Cancel G, Durr A, David G, Didierjean O et al. Screening for proteins with polyglutamine, expansions in autosomal dominant cerebellar ataxias. Hum Mol Genet 1996; 5: 1887-1892.
17. 17 Imbert G, Saudou F, Yvert G, Devys D, Trottier Y, Garnier JM et al. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nature Genet 1996; 14: 285-291.
18. 18 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Diseases, 4th edn, 1994.
19. 19 Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Iniative. Arch Gen Psychiatry 1994; 51: 849-859; discussion 863-864.
20. 20 Schurhoff F, Stevanin G, Trottier Y, Bellivier F, Mouren-Simeoni MC, Brice A et al. A preliminary study on early onset schizophrenia and bipolar disorder: large polyglutamine expansions are not involved. Psychiatry Res 1997; 72: 141-144.
21. 21 Jones A, Middle F, Guy C, Spurlock G, Cairns NJ, McGuffin P et al. No evidence for expanded polyglutamine sequences in bipolar disorder and schizophrenia. Mol Psychiatry 1998; 2: 478-482.
22. 22 Maier W, Lichtermann D, Minges J, Hallmayer J, Heun R, Benkert OX et al. Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study. Arch Gen Psychiatry 1993; 50: 871-883.